Al-Shymali Olena, McAlinden Colm, Alio Del Barrio Jorge L, Canto-Cerdan Mario, Alio Jorge L
Research & Development Department VISSUM Innovation and Department of Cornea, Cataract and Refractive Surgery, VISSUM Corporation, Alicante, Spain.
Department of Ophthalmology, Singleton Hospital, Swansea Bay University Health Board, Swansea, UK.
Eye Vis (Lond). 2022 Mar 1;9(1):8. doi: 10.1186/s40662-022-00280-8.
The aim of the study was to evaluate the outcomes of dissatisfied patients reporting poor visual quality following implantation of multifocal intraocular lenses (MF-IOLs), managed by IOL exchange with another multifocal optical profile.
This is a retrospective series of cases. MF-IOL exchange was done in 15 dissatisfied patients (30 eyes) with the perception of poor visual quality for far distance affected by neuroadaptation failure. Patients underwent a bilateral exchange of a MF-IOL with another MF-IOL of a different optical profile. Visual outcomes and complications were analyzed. Questionnaires including Quality of Vision (QoV), Visual Function Index-14 (VF-14) and its Rasch-revised version (VF-8R) and a satisfaction questionnaire were also used for outcome evaluation.
The mean elapsed time from implantation to explantation-reimplantation was 11.8 months. The QoV scores improved significantly across all the three subscales. Visual function improved with a change in VF-14 score from 60.41 ± 24.81 to 90.16 ± 10.91 (P < 0.001). The VF-8R score improved as well. The uncorrected distance visual acuity improved from 0.24 to 0.12 logMAR after exchange (P < 0.001) and corrected distance visual acuity improved from 0.15 to 0.04 logMAR (P < 0.001). Safety and efficacy indexes reached 1.46 and 1.16, respectively. Concerning patients' satisfaction following MF-IOL exchange, 80% of the patients reported they would have the MF-IOL reimplantation procedure again.
Patient dissatisfaction with neuroadaptation failure following MF-IOL implantation can be managed in 80% of our cases by MF-IOL exchange with a different MF-IOL optical profile.
本研究的目的是评估多焦点人工晶状体(MF-IOL)植入术后报告视觉质量差的不满意患者,通过更换为另一种多焦点光学设计的人工晶状体进行处理的效果。
这是一个回顾性病例系列。对15例(30只眼)因神经适应失败而感觉远距离视觉质量差的不满意患者进行了MF-IOL更换。患者接受了双侧MF-IOL更换,换为另一种不同光学设计的MF-IOL。分析了视觉效果和并发症。还使用了包括视觉质量(QoV)、视觉功能指数-14(VF-14)及其Rasch修订版(VF-8R)的问卷以及一份满意度问卷进行效果评估。
从植入到取出再植入的平均时间为11.8个月。QoV评分在所有三个子量表上均有显著改善。视觉功能有所改善,VF-14评分从60.41±24.81变为90.16±10.91(P<0.001)。VF-8R评分也有所提高。更换人工晶状体后,未矫正远视力从0.24 logMAR提高到0.12 logMAR(P<0.001),矫正远视力从0.15 logMAR提高到0.04 logMAR(P<0.001)。安全性和有效性指数分别达到1.46和1.16。关于患者对MF-IOL更换后的满意度,80%的患者表示他们愿意再次接受MF-IOL再植入手术。
在我们80%的病例中,MF-IOL植入术后因神经适应失败导致的患者不满意情况可通过更换为不同光学设计的MF-IOL来处理。